SCHEMBL4095158

SCHEMBL4095158

CC(C)Oc1ccc(-n2c(C(=O)O)c(N3CCCC3=O)c3nc(Oc4cccc(Cl)c4)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 1/20 0.38
PPARG P37231 2/20 0.36
HRH3 Q9Y5N1 3/20 0.36
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
P2RX3 P56373 1/20 0.35
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
F10 P00742 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
FFAR1 O14842 1/20 0.34
HRH1 P35367 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
MAPT P10636 1/20 0.34
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927867 0.84 TP53 (0.40) PPARGTP53P2RX3ALDH1A1HSD17B10
SCHEMBL4090165 0.84 PPARG (0.42) PPARGHRH3TSHRALDH1A1EGLN1
SCHEMBL4101567 0.77 MDM2 (0.43) PPARGHRH3EGLN1MAPT
SCHEMBL4922011 0.75 PPARG (0.42) PPARGHRH3TP53HRH1MAPT
SCHEMBL4094387 0.74 PTGES (0.47) PPARGHRH3LMNATP53HPGD
SCHEMBL4916712 0.72 PPARG (0.44) PPARGTP53MAPT
SCHEMBL4095879 0.72 PPARG (0.43) PPARGHRH3TSHRALDH1A1
SCHEMBL333839 0.71 PPARG (0.47) PPARG
SCHEMBL4224601 0.69 PTGES (0.58) ADRB3PPARGHPGDTSHRALDH1A1
SCHEMBL4095050 0.69 PTGES (0.48) ADRB3PPARGHRH3TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048285-A1 Pyrrolopyridines Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048285-A1 Pyrrolopyridines Useful in the Treatment of Inflammation PYCR1, ARG2, ARG1 ADRB3 530/4885PPARG 1316/4885HRH3 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.